Malignant hyperthermia (MH) or malignant hyperpyrexia is a rare life-threatening condition that is usually triggered by exposure to certain drugs used for general anaesthesia — specifically the volatile anaesthetic agents and succinylcholine, a neuromuscular blocking agent.
MH Resources
RESOURCE KIT
The Malignant Hyperthermia Resource Kit allows hospitals to better manage MH.
MH Training
The MH reading should take 1 hour followed by a short Q&A to test your competency.